Frontlight ResearchEarly access
Trial site
Kokikai Tsujinaka Hospital Kashiwanoha
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis4 trials
- Crohn's disease2 trials
- Phase
- Phase 34 trials
- Phase 22 trials
- Status
- Recruiting3 trials
- Completed2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Abivax S.A.2 trials
- Eli Lilly and Company2 trials
- Genentech, Inc.1 trial
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 trial
Running trials
Recruiting
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Recruiting
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease2 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026